Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailender Bhatia

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotypeAude G Chapuis, John A Thompson, Kim A Margolin, et al.
JAMA Dermatology|November 14, 2019
Age-Specific Incidence of Melanoma in the United StatesKelly G Paulson, Deepti Gupta, Teresa S Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2018
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced CancerNeil H Segal, Aiwu R He, Toshihiko Doi, et al.
Journal for Immunotherapy of Cancer|November 29, 2018
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapyNatalie J Miller, Candice D Church, Steven P Fling, et al.
Cancer|March 1, 2014
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapyJorge A Garcia, Gary R Hudes, Toni K Choueiri, et al.
Advances in Radiation Oncology|August 25, 2020
Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and NeckMaclean M Cook, Stephanie K Schaub, Peter H Goff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaShailender Bhatia, Natalie J Miller, Hailing Lu, et al.
Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.
Cancers|December 11, 2022
Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case-Control Study and Literature ReviewTomoko Akaike, Kelsey Cahill, Gensuke Akaike, et al.
International Journal of Particle Therapy|November 28, 2019
Does Neutron Radiation Therapy Potentiate an Immune Response to Merkel Cell Carcinoma?Stephanie K Schaub, Robert D Stewart, George A Sandison, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotypeAude G Chapuis, John A Thompson, Kim A Margolin, et al.
JAMA Dermatology|November 14, 2019
Age-Specific Incidence of Melanoma in the United StatesKelly G Paulson, Deepti Gupta, Teresa S Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2018
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced CancerNeil H Segal, Aiwu R He, Toshihiko Doi, et al.
Journal for Immunotherapy of Cancer|November 29, 2018
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapyNatalie J Miller, Candice D Church, Steven P Fling, et al.
Cancer|March 1, 2014
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapyJorge A Garcia, Gary R Hudes, Toni K Choueiri, et al.
Advances in Radiation Oncology|August 25, 2020
Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and NeckMaclean M Cook, Stephanie K Schaub, Peter H Goff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaShailender Bhatia, Natalie J Miller, Hailing Lu, et al.
Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.
Cancers|December 11, 2022
Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case-Control Study and Literature ReviewTomoko Akaike, Kelsey Cahill, Gensuke Akaike, et al.
International Journal of Particle Therapy|November 28, 2019
Does Neutron Radiation Therapy Potentiate an Immune Response to Merkel Cell Carcinoma?Stephanie K Schaub, Robert D Stewart, George A Sandison, et al.
Pageof 13